SOD1 and sarcopenia: GSH/GSSG (P < 0.001, Figure 7A) and SOD (P < 0.05, Figure 7B) levels of the HF + sarcopenia group were significantly increased after injection of levosimendan, and the oxidative stress was also alleviated.